| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 12/19/2007 | CN101090719A Injectable or orally deliverable formulations of azetidine derivatives |
| 12/19/2007 | CN101090707A Medicament for hygienic application inside the ear |
| 12/19/2007 | CN101088564A Intravenous medicine carrier material and its prepn process |
| 12/19/2007 | CN101088563A Anticancer composition containing lomustine |
| 12/19/2007 | CN101088562A Anticancer composition containing ranimustine |
| 12/19/2007 | CN101088558A Effervescent tablet of human interferon-alpha-2b and its prepn process |
| 12/19/2007 | CN101088524A Phosphatide composition of active skull cap components and its prepn process and prepn |
| 12/19/2007 | CN101088523A Nanometer solid lipid particle of active skullcap components and its prepn process and prepn |
| 12/19/2007 | CN101088522A Chinese medicine composition containing red sage, notoginseng and musk or muskone and its prepn |
| 12/19/2007 | CN101088516A Chinese medicine prepn for treating leukemia |
| 12/19/2007 | CN101088508A New medicinal use and medicine prepn of lily polysaccharide |
| 12/19/2007 | CN101088505A Nanometer breviscapine polymer particle prepn and its prepn process |
| 12/19/2007 | CN101088502A Mixture solution containing conjugate of transferrin and quercetin and its use |
| 12/19/2007 | CN101088500A Cold treating medicine for children |
| 12/19/2007 | CN101088499A Dry asarol emulsion and its prepn and application |
| 12/19/2007 | CN101088497A Composition containing lycopane and thioglycoside |
| 12/19/2007 | CN101088496A Microecological bifid bacterium signal molecule prepn and its prepn process |
| 12/19/2007 | CN101088494A Enteric coated granule and method for preparing the same |
| 12/19/2007 | CN101088493A Nanometer alprosadil particle and its prepn process |
| 12/19/2007 | CN101088492A Stable supersaturated gemcitabine hydrochloride solution and its prepn process |
| 12/19/2007 | CN101088491A Anticancer composition |
| 12/19/2007 | CN100355786C Polyethylene glycol-modified thymus peptide 1 derivatives |
| 12/19/2007 | CN100355784C Method for preparing polyethylene glycol-modified alpha-interferon 1b |
| 12/19/2007 | CN100355731C Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
| 12/19/2007 | CN100355457C Dispersible pharmaceutical compositions |
| 12/19/2007 | CN100355456C Calcium alginate/poly arginine-chitin glycan composite medicine release -controlled microcap sule and preparing method thereof |
| 12/19/2007 | CN100355455C Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 12/19/2007 | CN100355454C Nano-magnetic powder antihuman lirer cancer single anti HAb18 target medicine for magnetic heat therapy |
| 12/19/2007 | CN100355422C Pharmaceutical composition containing platinum complex as active substance and method of manufacturing thereof |
| 12/19/2007 | CN100355418C Magnetic nano-balls carried with cisplatin and its prepn. method |
| 12/19/2007 | CA2820023A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 12/19/2007 | CA2549115A1 Prebiotic and preservative uses of oil-emulsified probiotic encapsulations |
| 12/18/2007 | US7309759 Indolicidin peptide analogues containing at least two basic amino acids; bactericide |
| 12/18/2007 | US7309757 Polymers for the delivery of bioactive agents and methods of their preparation |
| 12/18/2007 | US7309719 Stabilized pharmaceutical preparation of gamma-aminobutyric acid derivatives and process for preparing the same |
| 12/18/2007 | US7309698 Compositions for delivering bisphosphonates |
| 12/18/2007 | US7309697 Cyclic maltosylmatose |
| 12/18/2007 | US7309694 Gene therapy; cytokine complex; anticancer agent |
| 12/18/2007 | US7309692 Inhibition of Grb2 and Crk1 gene products that interact with the bcr-abl product and participate in the transformation of Chronic myeloid leukemia |
| 12/18/2007 | US7309689 Sustained peptide-release formulation |
| 12/18/2007 | US7309502 Pharmaceutical compositions for treating and saving and the method for the preparation thereof |
| 12/18/2007 | US7309499 Mixture of pectin and glycerin; stabilization with calcium gluconate, sucrose fatty acid ester, acetic acid; molding; cooling in air |
| 12/18/2007 | US7309497 Injectable pharmaceutical composition for systematic administration of pharmacologically active ingredients |
| 12/18/2007 | CA2378436C Method for producing antibiotic composites |
| 12/18/2007 | CA2311754C A one dose syringe, comprising a freeze-dried protein composition, for administering of a volume less than 0.5 ml |
| 12/18/2007 | CA2280130C Lyophilized compositions containing sphingoglycolipid and process for preparing them |
| 12/18/2007 | CA2277377C Controlled release composition |
| 12/18/2007 | CA2268077C 1,3-bis-(n-lactamyl) propane and the pharmaceutical and cosmetic use thereof |
| 12/18/2007 | CA2235400C Cartilage/bone inducing materials for reparation |
| 12/18/2007 | CA2210076C Enrofloxacin injection or infusion solutions |
| 12/18/2007 | CA2103306C Extrudable compositions for topical or transdermal drug delivery |
| 12/18/2007 | CA2062047C Fusion proteins for prodrug activation, the preparation and use thereof |
| 12/15/2007 | CA2591350A1 Antacid and breath freshening composition |
| 12/13/2007 | WO2007143382A2 Oral liquid loratadine formulations and methods |
| 12/13/2007 | WO2007143381A2 Microparticles and methods for production thereof |
| 12/13/2007 | WO2007143311A2 Solid medicament dosage form consumption aid |
| 12/13/2007 | WO2007142596A1 Use of selected lactic acid bacteria for reducing infantile colic |
| 12/13/2007 | WO2007142295A1 Novel tape preparation |
| 12/13/2007 | WO2007142280A1 Hydrogel sheet and production method thereof |
| 12/13/2007 | WO2007142259A1 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2h-pyridazine-3-one-containing complex and process for producing the same |
| 12/13/2007 | WO2007142212A1 Preparation composition |
| 12/13/2007 | WO2007141806A1 Pharmaceutical formulations comprising oxcarbazepine and methods thereof |
| 12/13/2007 | WO2007141182A2 Utilization of vinyl acetate sulfonate copolymers as solubilizers for compounds with low solubility in water |
| 12/13/2007 | WO2007140613A1 Fermented milk product and use thereof |
| 12/13/2007 | WO2007140588A1 Pathogenic attenuation via the administration of an equilibiotic compound |
| 12/13/2007 | WO2007109104A3 Modified release formulations containing drug-ion exchange resin complexes |
| 12/13/2007 | WO2007095286A3 AQUEOUS PHARMACEUTICAL FORMULATIONS OF ERβ SELECTIVE LIGANDS |
| 12/13/2007 | WO2007038171A3 Peptide nucleic acid based guanidinium compounds |
| 12/13/2007 | WO2007037795A3 Stable aqueous protein or antibody pharmaceutical formulations and their preparation |
| 12/13/2007 | WO2006119128A3 Vascular targeting of ocular neovascularization |
| 12/13/2007 | WO2006116628A3 Enzymes conjugated to antiobodies via a peg heterobifuctional linker |
| 12/13/2007 | WO2006105148A3 Peg-poly(ortho ester) graft copolymers and pharmaceutical compositions |
| 12/13/2007 | WO2006095026A8 New soft gelatin capsules |
| 12/13/2007 | WO2005115417A3 Polycationic antimicrobial therapeutic |
| 12/13/2007 | WO2003017923A3 Anticancer polypeptide-metal complexes and compositions, methods of making, and methods of using same |
| 12/13/2007 | US20070287826 Production of high molecular mass lectins |
| 12/13/2007 | US20070287825 Constrained cis-diol-borate bioconjugation system |
| 12/13/2007 | US20070287756 Methods and Compositions for Preserving the Viability of Photoreceptor Cells |
| 12/13/2007 | US20070287749 Bromfenac ophthalmic formulations and methods of use |
| 12/13/2007 | US20070287714 Warming and Nonirritating Lubricant Compositions and Method of Comparing Irritation |
| 12/13/2007 | US20070287688 Pharmaceutical Compositions for Topical Application |
| 12/13/2007 | US20070287682 Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| 12/13/2007 | US20070287680 Combined Active and Passive Targeting of Biologically Active Agents |
| 12/13/2007 | US20070287671 Compositions and Methods for Promoting Myocardial and Peripheral Angiogenesis |
| 12/13/2007 | US20070287177 Bonding to monoclonal antibodies; antitumor agents |
| 12/13/2007 | US20070287173 Therapeutic polypeptide with prolonged shelf-life and increased half life for use in treatment of cell proliferative, cardiovascular, inflammatory and autoimmune disorders |
| 12/13/2007 | US20070286898 Intracellular Drug Delivery Improving Liposome |
| 12/13/2007 | US20070286896 Therapeutic or Diagnostic Drug for Inflammatory Disease Comprising Targeting Liposome |
| 12/13/2007 | US20070286889 Weight management system for obese animals |
| 12/13/2007 | US20070286887 Fine powder of amino acid and suspension thereof |
| 12/13/2007 | US20070286886 Materials And Methods For Inducing Apoptosis In Adipocytes |
| 12/13/2007 | US20070286881 Method, composition and kit for treating degenerated disc disease and discogenic pain |
| 12/13/2007 | US20070286876 Skin care compositions comprising low concentrations of skin treatment agents |
| 12/13/2007 | US20070286868 Phosphorylcholine Conjugates and Corresponding Antibodies |
| 12/13/2007 | US20070286852 Sppls as Modifiers of the P53 Pathway and Methods of Use |
| 12/13/2007 | US20070286829 Antiperspirant Or Deodorant Compositions |
| 12/13/2007 | DE19529057B4 Ifosfamid-Lyophilisat-Zubereitungen Ifosfamide lyophilized preparations |
| 12/13/2007 | CA2839795A1 Self-assembling monomers and oligomers as surface-modifying endgroups for polymers |
| 12/13/2007 | CA2654457A1 Fermented milk product and use thereof |
| 12/13/2007 | CA2654082A1 Use of micron-sized sulphur for the prevention and treatment of pathogenic disorders in humans and animals |